Related Experiment Video
Updated: Nov 16, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Podocyte apoptosis in diabetic nephropathy by BASP1 activation of the p53 pathway via WT1
Yingying Zhang1, Chengxian Xu1, Qing Ye1
1Department of Nephrology, The Children Hospital of Zhejiang University School of Medicine, National Clinical Research Center for Child Health, National Children's Regional Medical Center, Hangzhou, China.
Aims:
Diabetic nephropathy (DN) is a leading cause of end-stage renal disease. BASP1 (brain acid-soluble protein) is up-regulated in podocyte-specific protein phosphatase 2A knockout mice (Pod-PP2A-KO) that develop kidney dysfunction. Here, we explore the role of BASP1 for podocytes in DN.
Methods:
BASP1 was assessed in kidneys from DN patients and DN mouse models, podocyte specific BASP1 knockout mice (Pod-BASP1-KO mice) were generated and studied in vivo. Furthermore, podocyte injury and apoptosis were measured after BASP1 knockdown and overexpression in a mouse podocyte cell line (MPC5). Potential signalling pathways involved in podocyte apoptosis were detected.
Results:
BASP1 expression was up-regulated in DN patients compared to normal controls. BASP1 specific deletion in podocytes protected against podocyte injury by reducing the loss of expression of slit diaphragm molecules and foot process effacement in the DN model. BASP1 promoted actin cytoskeleton rearrangements and apoptosis in the MPC5 podocyte line. Molecules involved in the p53 pathway were down-regulated in BASP1 knockdown podocytes treated with high glucose compared to controls. BASP1 promoted podocyte apoptosis and P53 pathway activation through co-repression with Wilms' tumour 1 transcription factor (WT1).
Conclusion:
BASP1 activates the p53 pathway through modulation of WT1 to induce podocyte apoptosis in diabetic nephropathy.
Insights
Brain acid-soluble protein (BASP1) is elevated in diabetic nephropathy (DN). Deleting BASP1 in podocytes protects kidneys. BASP1 activates the p53 pathway, inducing podocyte apoptosis in DN.
Area of Science:
- Nephrology
- Molecular Biology
- Cell Biology
Background:
- Diabetic nephropathy (DN) is a major cause of end-stage renal disease.
- Brain acid-soluble protein (BASP1) is upregulated in podocytes in kidney dysfunction models.
Purpose of the Study:
- To investigate the role of BASP1 in podocytes during diabetic nephropathy.
- To elucidate the molecular mechanisms by which BASP1 affects podocyte injury and apoptosis.
Main Methods:
- BASP1 expression analysis in human DN kidneys and mouse models.
- Generation and study of podocyte-specific BASP1 knockout mice (Pod-BASP1-KO).
- In vitro studies using mouse podocyte cell line (MPC5) with BASP1 knockdown/overexpression to assess apoptosis and signaling pathways.
Main Results:
- BASP1 expression is increased in DN patients and mouse models.
- Podocyte-specific deletion of BASP1 ameliorates podocyte injury and protects against DN.
- BASP1 promotes podocyte apoptosis and actin cytoskeleton rearrangement.
- BASP1 co-represses with WT1 to activate the p53 pathway in high glucose-treated podocytes.
Conclusions:
- BASP1 plays a critical role in promoting podocyte apoptosis in diabetic nephropathy.
- BASP1 activates the p53 pathway via WT1 modulation, leading to podocyte injury in DN.
- Targeting BASP1 may offer a therapeutic strategy for diabetic nephropathy.
More Related Videos
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
06:16White and Brown Adipose Grafts: An Approach to Correct Reproductive, Metabolic, and Renal Deficits in Black and Tan Brachyury (BTBR) Obese Mice
Published on: September 9, 2025
Related Concept Videos
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
Canonical Wnt Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
The JAK-STAT Signaling Pathway
The Extrinsic Apoptotic Pathway